Tumor response to immunochemotherapy may spare some head and neck cancer patients radical surgery
Medical Xpress 1 views
Topic timeline
How reporting on this topic developed over time — coverage by day, outlet counts, and multi-source storylines where they exist.
Coverage evolution
Not enough independent coverage yet to show how reporting developed. The facts below are direct observations from the tracked window.
First detected
Coverage first appeared in the tracked window.
ZTE and partners nurture global ICT talent through 2026 engineering capacity building program The Register · Jun 3, 2026Latest update
Most recent tracked report from Medical Xpress.
Tumor response to immunochemotherapy may spare some head and neck cancer patients radical surgery Medical Xpress · 3h ago3 reports in date order. Not enough independent coverage yet to show a development timeline.